The ability to harness a cell’s innate machinery to produce specific agents was revolutionary for drug development. Today, fields from biopharmaceutical production to food processing use biomanufacturing. However, cell-based production methods bring their own caveats, one of which is the presence of host cell proteins (HCPs).

Download the white paper to learn how to reduce the risk of unexpected HCPs in your biomanufacturing process, courtesy of Cytiva.